XML 41 R30.htm IDEA: XBRL DOCUMENT v3.24.3
SEGMENTS (Tables)
 9 Months Ended
Sep. 30, 2024
SEGMENTS [Abstract]  
Summarized Financial Information Concerning Reportable Segments Summarized financial information concerning reportable segments is shown in the following tables:

Three Months Ended September 30, 2024
  
    ADMA    
Plasma Collection
             
(in thousands)  
BioManufacturing
    
Centers
    
Corporate
    
Consolidated
  
                         
Revenues
  
$
113,088
    
$
6,715
    
$
36
    
$
119,839
  
                                 
Cost of product revenue
    
52,731
      
7,449
      
-
      
60,180
  
                                 
Income (loss) from operations
    
48,347
      
(1,755
)
    
(6,954
)
    
39,638
  
                                 
Interest and other expense, net
    
(54
)
    
-
   
(2,835
)
    
(2,889
)
                                 
Income (loss) before taxes
    
48,293
      
(1,755
)
    
(9,789
)
    
36,749
  

                               
Depreciation and amortization expense
   
1,138
      
802
      
-
      
1,940
  
Total assets
     266,456       33,191       90,971       390,618  

Three Months Ended September 30, 2023
  
    ADMA    
Plasma Collection
             
(in thousands)  
BioManufacturing
    
Centers
    
Corporate
    
Consolidated
  
                         
Revenues
  
$
66,567
    
$
672
    
$
36
    
$
67,275
  
                                 
Cost of product revenue
    
41,734
      
888
      
-
      
42,622
  
                                 
Income (loss) from operations
    
15,017
      
(683
)
    
(5,649
)
    
8,685
                                 
Interest and other (expense) income, net
    
(141
)
    
-
      
(5,979
)
    
(6,120
)
                                 
Income (loss) before taxes
    
14,876
      
(683
)
    
(11,628
)
    
2,565
                                 
Depreciation and amortization expense
    
1,282
      
811
      
-
      
2,093
  
Total assets     262,554       35,622       50,821       348,997  

Nine Months Ended September 30, 2024
  
    ADMA    
Plasma Collection
             
(in thousands)  
BioManufacturing
    
Centers
    
Corporate
    
Consolidated
  
                         
Revenues
  
$
299,385
    
$
9,413
    
$
107
    
$
308,905
  
                                 
Cost of product revenue
     142,193
      
10,492
      
-
      
152,685
  
                                 
Income (loss) from operations
     123,756      
(4,047
)
    
(19,049
)
    
100,660
  
                                 
Interest and other expense, net
     (95 )    
(4
)
    
(9,560
)
    
(9,659
)
                                 
Income (loss) before taxes
    
123,661
      
(4,051
)
    
(28,609
)
    
91,001
  
                                 
Capital expenditures
     5,364       105       -       5,469  
Depreciation and amortization expense
    
3,686
      
2,415
      
-
      
6,101
  

Nine Months Ended September 30, 2023
  
    ADMA    
Plasma Collection
             
(in thousands)  
BioManufacturing
    
Centers
    
Corporate
    
Consolidated
  
                         
Revenues
  
$
175,905
    
$
8,299
    
$
107
    
$
184,311
  
                                 
Cost of product revenue
    
118,708
      
7,747
      
-
      
126,455
  
                                 
Income (loss) from operations
    
26,577
      
(3,029
)
    
(16,149
)
    
7,399
                                 
Interest and other expense, net
    
(170
)
    
-
      
(17,823
)
    
(17,993
)
                                 
Income (loss) before taxes
    
26,407
      
(3,029
)
    
(33,972
)
    
(10,594
)
                                 
Capital expenditures
     1,768       1,806       -       3,574  
Depreciation and amortization expense
    
3,857
      
2,366
      
-
      
6,223
  
Net Revenues According to Geographic Area
Net revenues according to geographic area, based on the location of where the product is shipped, is as follows:
   
Three Months Ended September 30,
    
Nine Months Ended September 30,
  
(in thousands)  
2024
   
2023
   
2024
   
2023
 
United States
  
$
114,748
    
$
64,618
    
$
295,465
    
$
173,920
  
International
    
5,091
      
2,657
      
13,440
      
10,391
  
Total revenues
  
$
119,839
    
$
67,275
    
$
308,905
    
$
184,311